Northwest Medical Isotopes, LLC; Medical Radioisotope Production Facility, 22532-22534 [2018-10273]
Download as PDF
<![CDATA[
22532
Federal Register / Vol. 83, No. 94 / Tuesday, May 15, 2018 / Notices
Agency: RAILROAD RETIREMENT BOARD
Bureau: Railroad Retirement Board
Account: Railroad Unemployment Insurance
Extended Benefits Payments (060-0117/X)
Amount proposed for rescission:
$132,612,397
Proposed rescission appropriations
language:
Of the amounts made available in section
9 of the Worker, Homeownership, and
Business Assistance Act of 2009 (Public Law
111–92), $132,612,397 are rescinded.
Justification:
This proposal would rescind $133 million
in prior year balances of which there were
slightly more than $133 million available on
October 1, 2017. These funds were enacted
to pay extended unemployment insurance
benefits to railroad workers. The program
expired on December 31, 2012 and the
remaining funding is no longer needed.
Enacting the rescission would not have any
programmatic impact on the program. The
proposed rescission would have no effect on
outlays.
www.mmc.gov/wp-content/uploads/
MMC-2018-Annual-Meeting-Agenda_
Public_27April2018.pdf and will be
updated as necessary.
FOR FURTHER INFORMATION CONTACT: The
Marine Mammal Commission, 4340
East-West Highway, Room 700,
Bethesda, MD 20814; (301) 504–0087;
email: mmc@mmc.gov.
Dated: May 8, 2018.
Peter O. Thomas,
Executive Director.
[FR Doc. 2018–10376 Filed 5–11–18; 11:15 am]
BILLING CODE 6820–31–P
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
60-Day Notice for the ‘‘Agency
Initiatives Poetry Out Loud or the
Musical Theater Songwriting Challenge
for High School Students’’
MARINE MAMMAL COMMISSION
National Endowment for the
Arts, National Foundation on the Arts
and the Humanities.
ACTION: Notice of proposed collection;
comment request.
Sunshine Act Notice
SUMMARY:
AGENCY:
[FR Doc. 2018–10251 Filed 5–14–18; 8:45 am]
BILLING CODE 3110–01–P
The Marine Mammal
Commission and its Committee of
Scientific Advisors on Marine Mammals
will hold a public meeting on Tuesday,
29 May 2018, from 10:30 a.m. to 5:30
p.m.; Wednesday, 30 May 2018 from
8:30 a.m. to 5:30 p.m.; and Thursday, 31
May 2018, from 8:30 a.m. to 5:00 p.m.
The Commission and the Committee
also will meet in executive session on
Tuesday, 29 May 2018, from 8:30 to
10:00 a.m.
PLACE: Courtyard Ballroom, Renaissance
Seattle Hotel, 515 Madison Street,
Seattle, Washington.
STATUS: The executive session will be
closed to the public in accordance with
the provisions of the Government in the
Sunshine Act (5 U.S.C. 552b) and
applicable regulations. The session will
be limited to discussions of internal
agency practices and personnel. All
other portions of the meeting will be
open to the public. Public participation
will be allowed as time permits and as
determined to be desirable by the
Chairman.
MATTERS TO BE CONSIDERED: The
Commission and Committee will meet
in public session to discuss a broad
range of marine mammal science and
conservation issues, with a particular
focus on issues related to the Pacific
Northwest and the West Coast. A draft
agenda for the meeting is posted on the
Commission’s website at https://
daltland on DSKBBV9HB2PROD with NOTICES
TIME AND DATE:
VerDate Sep<11>2014
20:27 May 14, 2018
Jkt 244001
The National Endowment for
the Arts (NEA), as part of its continuing
effort to reduce paperwork and
respondent burden, conducts a
preclearance consultation program to
provide the general public and federal
agencies with an opportunity to
comment on proposed and/or
continuing collections of information in
accordance with the Paperwork
Reduction Act of 1995. This program
helps to ensure that requested data is
provided in the desired format;
reporting burden (time and financial
resources) is minimized; collection
instruments are clearly understood; and
the impact of collection requirements on
respondents is properly assessed.
Currently, the NEA is soliciting
comments concerning the proposed
information collection for applications
from students for Agency Initiatives
Poetry Out Loud or the Musical Theater
Songwriting Challenge for High School
Students. A copy of the current
information collection request can be
obtained by contacting the office listed
below in the address section of this
notice.
DATES: Written comments must be
submitted to the office listed in the
address section below within 60 days
from the date of this publication in the
Federal Register. The NEA is
particularly interested in comments
that:
• Evaluate whether the proposed
collection of information is necessary
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Can help the agency minimize the
burden of the collection of information
on those who are to respond, including
through the electronic submission of
responses.
Email comments to Jillian
Miller, Director, Office of Guidelines
and Panel Operations, National
Endowment for the Arts, at: millerj@
arts.gov.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Jillian Miller, Director of Guidelines and
Panel Operations, National Endowment
for the Arts, at millerj@arts.gov or (202)
682–5504.
Dated: May 9, 2018.
Jillian LeHew Miller,
Director, Office of Guidelines and Panel
Operations, Administrative Services, National
Endowment for the Arts.
[FR Doc. 2018–10270 Filed 5–14–18; 8:45 am]
BILLING CODE 7537–01–P
NUCLEAR REGULATORY
COMMISSION
[Docket No. 50–609; NRC–2013–0235]
Northwest Medical Isotopes, LLC;
Medical Radioisotope Production
Facility
Nuclear Regulatory
Commission.
ACTION: Construction permit and record
of decision; issuance.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC or the Commission)
is providing notice of the issuance of
Construction Permit No. CPMIF–002 to
Northwest Medical Isotopes, LLC
(NWMI) and record of decision (ROD).
DATES: The construction permit was
issued, and is immediately effective,
May 9, 2018.
ADDRESSES: Please refer to Docket ID
NRC–2013–0235 when contacting the
NRC about the availability of
information regarding this document.
You may obtain publicly-available
information related to this document
using any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov and search
SUMMARY:
E:\FR\FM\15MYN1.SGM
15MYN1
22533
Federal Register / Vol. 83, No. 94 / Tuesday, May 15, 2018 / Notices
for Docket ID NRC–2013–0235. Address
questions about NRC dockets to Jennifer
Borges; telephone: 301–287–9127;
email: Jennifer.Borges@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209 or 301–415–4737, or
by email to pdr.resource@nrc.gov. For
the convenience of the reader, the
ADAMS accession numbers are
provided in a table in the ‘‘Availability
of Documents’’ section of this
document.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT:
Michael Balazik, Office of Nuclear
Reactor Regulation, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001; telephone: 301–415–
2856; email: Michael.Balazik@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Introduction
Under section 2.106 of title 10 of the
Code of Federal Regulations (10 CFR),
the NRC is providing notice of the
issuance of Construction Permit No.
CPMIF–002 to NWMI and the issuance
of the ROD under 10 CFR 51.102(c). The
construction permit, which is
immediately effective, authorizes NWMI
to construct a 10 CFR part 50
production facility designed for the
production of medical radioisotopes in
Columbia, Missouri, as described in
NWMI’s application for a construction
permit and in evidence received at the
mandatory hearing held by the
Commission. With respect to the
application for the construction permit
filed by NWMI, the NRC finds that the
applicable standards and requirements
of the Atomic Energy Act of 1954, as
amended, and the Commission’s
regulations have been met. The NRC
finds that any required notifications to
other agencies or bodies have been duly
made and that, among other things,
there is reasonable assurance that the
activities authorized by the permit will
be conducted in compliance with the
rules and regulations of the
Commission, that safety questions will
be satisfactorily resolved by the
completion of construction, and that,
taking into consideration siting criteria,
the proposed facility can be constructed
and operated at the proposed location
without undue risk to the public health
and safety, subject to the conditions
listed in the construction permit.
Furthermore, the NRC finds that the
licensee is technically and financially
qualified to engage in the activities
authorized, and that issuance of the
license will not be inimical to the
common defense and security or to the
health and safety of the public. Finally,
the NRC finds that the findings required
by subpart A of 10 CFR part 51 have
been made.
II. Further Information
The NRC prepared a safety evaluation
report and a final environmental impact
statement that document the
information reviewed and the NRC’s
conclusions. The Commission also
issued its Memorandum and Order
(CLI–18–06), documenting its final
decision on the mandatory hearing held
on January 23, 2018, which serves as the
ROD in this proceeding. The
Commission’s final decision authorized
the issuance of the construction permit
for the NWMI medical radioisotope
production facility, contingent upon the
inclusion of a revised safety permit
condition. The NRC also prepared a
document summarizing the ROD to
accompany its action on the
construction permit application that
incorporates by reference materials
contained in the final environmental
impact statement. In accordance with 10
CFR 2.390 of the NRC’s ‘‘Agency Rules
of Practice and Procedure,’’ details with
respect to this action, including the
safety evaluation report, final
environmental impact statement,
summary ROD, and accompanying
documentation included in the
construction permit package, as well as
the Commission’s hearing decision and
ROD, are available online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. From this site, persons can
access the NRC’s ADAMS, which
provides text and image files of NRC’s
public documents. In addition, prior to
its publication as a NUREG document,
the NRC staff will update the safety
evaluation report to reflect the revised
permit condition.
III. Availability of Documents
The documents identified in the
following table are available to
interested persons through one or more
of the following methods, as indicated.
ADAMS
Accession
No.
Document
daltland on DSKBBV9HB2PROD with NOTICES
Construction Permit No. CPMIF–002 ...............................................................................................................................................
Commission’s Memorandum and Order (CLI-18–06) on the Mandatory Hearing (ROD) ...............................................................
Summary of the Record of Decision ................................................................................................................................................
Safety Evaluation Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production
Facility.
NUREG–2209, ‘‘Environmental Impact Statement for the Construction Permit for the Northwest Medical Isotopes Radioisotope
Production Facility: Final Report’’.
NWMI Construction Permit Application ............................................................................................................................................
VerDate Sep<11>2014
20:27 May 14, 2018
Jkt 244001
PO 00000
Frm 00093
Fmt 4703
Sfmt 9990
E:\FR\FM\15MYN1.SGM
15MYN1
ML18037A308
ML18123A374
ML18053A074
ML18016A021
ML17130A862
ML15210A182
ML17257A019
22534
Federal Register / Vol. 83, No. 94 / Tuesday, May 15, 2018 / Notices
Dated at Rockville, Maryland, this 9th day
of May 2018.
For the Nuclear Regulatory Commission.
Anita L. Lund,
Director, Division of Licensing Projects, Office
of Nuclear Reactor Regulation.
[FR Doc. 2018–10273 Filed 5–14–18; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[Docket No. 11005323; NRC–2018–0080]
Diversified Scientific Services, Inc.
Nuclear Regulatory
Commission.
ACTION: Export license amendment and
renewal application; opportunity to
comment, request a hearing, and
petition for leave to intervene.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is considering
issuing an export license amendment
and renewal of License No. XW008/05
requested by Diversified Scientific
Services, Inc. (DSSI). On February 9,
2018, DSSI submitted a revised
application with the NRC to amend and
renew License No. XW008/04. The
request seeks the NRC’s approval for
renewal and amendment of an existing
license authorizing the export of
radioactive waste to Canada. The NRC is
providing notice of the opportunity to
request a hearing on DSSI’s revised
application.
SUMMARY:
Submit comments by June 14,
2018. Requests for a hearing or a
petition for leave to intervene must be
filed by June 14, 2018.
ADDRESSES: You may submit comments
by any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov and search
for Docket ID NRC–2018–0080. Address
questions about NRC dockets to Jennifer
Borges; telephone: 301–287–9127;
email: Jennifer.Borges@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
daltland on DSKBBV9HB2PROD with NOTICES
DATES:
VerDate Sep<11>2014
20:27 May 14, 2018
Jkt 244001
email to pdr.resource@nrc.gov. The
ADAMS accession number for each
document referenced (if it is available in
ADAMS) is provided the first time that
it is mentioned in this document.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT:
Andrea R. Jones, Office of International
Programs, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001; telephone: 301–287–9072, email:
Andrea.Jones2@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2018–
0080 when contacting the NRC about
the availability of information for this
action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov and search
for Docket NRC–2018–0080.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
DSSI export license amendment and
renewal application is available in
ADAMS under Accession No.
ML18085A690.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
B. Submitting Comments
Please include Docket ID NRC–2018–
0080 in your comment submission.
The NRC cautions you not to include
identifying or contact information that
you do not want to be publicly
disclosed in your comment submission.
The NRC will post all comment
submissions at https://
www.regulations.gov as well as enter the
comment submissions into ADAMS.
The NRC does not routinely edit
comment submissions to remove
identifying or contact information.
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
If you are requesting or aggregating
comments from other persons for
submission to the NRC, then you should
inform those persons not to include
identifying or contact information that
they do not want to be publicly
disclosed in their comment submission.
Your request should state that the NRC
does not routinely edit comment
submissions to remove such information
before making the comment
submissions available to the public or
entering the comment into ADAMS.
II. Discussion
In accordance with section 110.70(b)
of title 10 of the Code of Federal
Regulations (10 CFR), the NRC is
noticing the receipt of an export license
amendment and renewal application
submitted by DSSI on February 9, 2018,
for the export of Canadian-origin lowlevel radioactive waste from the State of
Tennessee to Canada. The existing
license authorizes the export of up to
378,000 kilograms of treated and
processed low-level radioactive waste.
The amendment and renewal requests:
(1) An extension of the license from
March 31, 2017 to March 31, 2022; (2)
a change to the license point of contact;
(3) a change in the name of one ultimate
foreign consignee from Atomic Energy
of Canada Limited to Canadian Nuclear
Laboratories; (4) removal of the
reference to Waste Classification as
defined in 10 CFR 61.55 and reference
to Table A2 values of 49 CFR 173.435
from the waste description, since 10
CFR 61.55 is not applicable because
treated and processed waste are to be
returned to Canada; (5) removal of
previous references to Import License
No. IW012/05; (6) updated of
radioactivity levels; (7) inclusion of a
port of exit in the State of New York and
a port of exit in the State of Michigan.
The NRC is noticing the request to
amend and renew the license to export
radioactive waste, open the opportunity
for public comment, and open the
opportunity to file a request for a
hearing or petition for leave to intervene
to June 14, 2018. Any request for
hearing or petition for leave to intervene
shall be served by the requestor or
petitioner upon the applicant, the Office
of the General Counsel, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555; the Secretary, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555; and the Executive Secretary,
U.S. Department of State, Washington,
DC 20520. Hearing requests and
intervention petitions must include the
information specified in 10 CFR
110.82(b).
A request for a hearing or petition for
leave to intervene may be filed with the
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 83, Number 94 (Tuesday, May 15, 2018)]
[Notices]
[Pages 22532-22534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10273]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Docket No. 50-609; NRC-2013-0235]
Northwest Medical Isotopes, LLC; Medical Radioisotope Production
Facility
AGENCY: Nuclear Regulatory Commission.
ACTION: Construction permit and record of decision; issuance.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC or the Commission)
is providing notice of the issuance of Construction Permit No. CPMIF-
002 to Northwest Medical Isotopes, LLC (NWMI) and record of decision
(ROD).
DATES: The construction permit was issued, and is immediately
effective, May 9, 2018.
ADDRESSES: Please refer to Docket ID NRC-2013-0235 when contacting the
NRC about the availability of information regarding this document. You
may obtain publicly-available information related to this document
using any of the following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search
[[Page 22533]]
for Docket ID NRC-2013-0235. Address questions about NRC dockets to
Jennifer Borges; telephone: 301-287-9127; email:
[email protected]. For technical questions, contact the
individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209 or 301-415-4737, or by email to [email protected].
For the convenience of the reader, the ADAMS accession numbers are
provided in a table in the ``Availability of Documents'' section of
this document.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2856; email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Introduction
Under section 2.106 of title 10 of the Code of Federal Regulations
(10 CFR), the NRC is providing notice of the issuance of Construction
Permit No. CPMIF-002 to NWMI and the issuance of the ROD under 10 CFR
51.102(c). The construction permit, which is immediately effective,
authorizes NWMI to construct a 10 CFR part 50 production facility
designed for the production of medical radioisotopes in Columbia,
Missouri, as described in NWMI's application for a construction permit
and in evidence received at the mandatory hearing held by the
Commission. With respect to the application for the construction permit
filed by NWMI, the NRC finds that the applicable standards and
requirements of the Atomic Energy Act of 1954, as amended, and the
Commission's regulations have been met. The NRC finds that any required
notifications to other agencies or bodies have been duly made and that,
among other things, there is reasonable assurance that the activities
authorized by the permit will be conducted in compliance with the rules
and regulations of the Commission, that safety questions will be
satisfactorily resolved by the completion of construction, and that,
taking into consideration siting criteria, the proposed facility can be
constructed and operated at the proposed location without undue risk to
the public health and safety, subject to the conditions listed in the
construction permit. Furthermore, the NRC finds that the licensee is
technically and financially qualified to engage in the activities
authorized, and that issuance of the license will not be inimical to
the common defense and security or to the health and safety of the
public. Finally, the NRC finds that the findings required by subpart A
of 10 CFR part 51 have been made.
II. Further Information
The NRC prepared a safety evaluation report and a final
environmental impact statement that document the information reviewed
and the NRC's conclusions. The Commission also issued its Memorandum
and Order (CLI-18-06), documenting its final decision on the mandatory
hearing held on January 23, 2018, which serves as the ROD in this
proceeding. The Commission's final decision authorized the issuance of
the construction permit for the NWMI medical radioisotope production
facility, contingent upon the inclusion of a revised safety permit
condition. The NRC also prepared a document summarizing the ROD to
accompany its action on the construction permit application that
incorporates by reference materials contained in the final
environmental impact statement. In accordance with 10 CFR 2.390 of the
NRC's ``Agency Rules of Practice and Procedure,'' details with respect
to this action, including the safety evaluation report, final
environmental impact statement, summary ROD, and accompanying
documentation included in the construction permit package, as well as
the Commission's hearing decision and ROD, are available online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. From this site, persons can access the NRC's ADAMS, which
provides text and image files of NRC's public documents. In addition,
prior to its publication as a NUREG document, the NRC staff will update
the safety evaluation report to reflect the revised permit condition.
III. Availability of Documents
The documents identified in the following table are available to
interested persons through one or more of the following methods, as
indicated.
------------------------------------------------------------------------
Document ADAMS Accession No.
------------------------------------------------------------------------
Construction Permit No. CPMIF-002...... ML18037A308
Commission's Memorandum and Order ML18123A374
(CLI[dash]18-06) on the Mandatory
Hearing (ROD).
Summary of the Record of Decision...... ML18053A074
Safety Evaluation Report Related to the ML18016A021
Northwest Medical Isotopes, LLC
Construction Permit Application for a
Production Facility.
NUREG-2209, ``Environmental Impact ML17130A862
Statement for the Construction Permit
for the Northwest Medical Isotopes
Radioisotope Production Facility:
Final Report''.
NWMI Construction Permit Application... ML15210A182
ML17257A019
------------------------------------------------------------------------
[[Page 22534]]
Dated at Rockville, Maryland, this 9th day of May 2018.
For the Nuclear Regulatory Commission.
Anita L. Lund,
Director, Division of Licensing Projects, Office of Nuclear Reactor
Regulation.
[FR Doc. 2018-10273 Filed 5-14-18; 8:45 am]
BILLING CODE 7590-01-P
